Cecilia Bahit, M., Lopes, R. D., Hohnloser, S. H., Wojdyla, D., Alexander, J. H., Lewis, B. S., … Wallentin, L. (2012). Apixaban in Patients with Atrial Fibrillation and Prior Coronary Artery Disease: Insights from the ARISTOTLE Trial. CIRCULATION, 126(21).

Cecilia Bahit, Maria, Renato D. Lopes, Stephan H. Hohnloser, Daniel Wojdyla, John H. Alexander, Basil S. Lewis, Philip Aylward, et al. “Apixaban in Patients with Atrial Fibrillation and Prior Coronary Artery Disease: Insights from the ARISTOTLE Trial.” CIRCULATION 126, no. 21 (November 20, 2012).

Cecilia Bahit M, Lopes RD, Hohnloser SH, Wojdyla D, Alexander JH, Lewis BS, et al. Apixaban in Patients with Atrial Fibrillation and Prior Coronary Artery Disease: Insights from the ARISTOTLE Trial. CIRCULATION. 2012 Nov 20;126(21).

Cecilia Bahit, Maria, et al. “Apixaban in Patients with Atrial Fibrillation and Prior Coronary Artery Disease: Insights from the ARISTOTLE Trial.” CIRCULATION, vol. 126, no. 21, LIPPINCOTT WILLIAMS & WILKINS, Nov. 2012.

Cecilia Bahit M, Lopes RD, Hohnloser SH, Wojdyla D, Alexander JH, Lewis BS, Aylward P, Verheugt FW, Keltai M, Diaz R, Mohan P, Granger CB, Wallentin L. Apixaban in Patients with Atrial Fibrillation and Prior Coronary Artery Disease: Insights from the ARISTOTLE Trial. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2012 Nov 20;126(21).